Symposia Abstracts
NS17 - Nuovi bersagli farmacologici nella malattia di Parkinson
| ELECTROPHYSIOLOGICAL PROPERTIES OF DOPAMINERGIC NEURONS IN PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS Berretta ., Ledonne A., Mango D., Guatteo E., Federici M., Krashia P., Nisticò R., Mercuri N. |
| NEW INSIGHTS INTO PARKINSON’S DISEASE PATHOGENESIS FROM THE STUDY OF THE SYNAPTIC ALPHA-SYNUCLEIN PROTEOME Bellucci A., Zaltieri M., Grigoletto J., Navarria L., Castrezzati S., Rezzani R., Colivicchi M., DellaCorte L., Spillantini M., Missale C., Spano P. |
| LRRK2 KINASE ACTIVITY MODULATES PRESYNAPTIC VESICLE RELEASE Cirnaru M., Belluzzi E., Murru L., Marte A., Gabrielli M., Matteoli M., Passafaro M., Onofri F., Greggio E., Piccoli G. |
| HYPERPOLARIZATION-ACTIVATED CURRENT, MIDBRAIN DOPAMINE NEURONS AND PARKINSON’S DISEASE Masi A., Narducci R., Landucci E., Moroni F., Mannaioni G. |
| ASSEMBLIES OF GLUTAMATE RECEPTOR SUBUNITS WITHIN THE EXCITATORY SYNAPSE: NEW POSSIBLE TARGET IN PARKINSON'S DISEASE Gardoni F., Zianni E., Mellone M., Stanic J., DiLuca M. |